Actavis vector logo
Free to download Actavis vector logo in .EPS vector format. Browse to see more Actavis related vector logos. Download Actavis vector logo in .EPS format, and open with Adobe Illustrator or Adobe PhotoShop or CorelDRAW.
The current status of the logo is active, which means the logo is currently in use.
Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing, and distributing generic, brand, and biosimilar products. The Company has global and U.S. headquarters in Parsippany-Troy Hills, New Jersey, and international headquarters in Zug, Switzerland.
Actavis is the new name for global pharmaceutical Company Watson Pharmaceuticals Inc. as of January 24, 2013. At the same time the company began trading under a new ticker symbol (“ACT”) on the New York Stock Exchange.
The name change followed the company’s acquisition of the global Generics Pharmaceutical Company Actavis Group in October 2012.
Actavis is the world’s third-largest generics prescription drug manufacturer. Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands, and Over-the-Counter (OTC) products in more than 60 countries. The Company is ranked in the top 3 in 12 global markets, the top 5 in 16 global markets, and in the top 10 in 33 global markets. Actavis Pharma also develops and out-licenses generic pharmaceutical products outside the U.S. through its Medis third-party business, the world’s largest generic pharmaceutical out-licensing business. Medis has more than 300 customers globally, and offers a broad portfolio of more than 200 products.
Actavis Specialty Brands is the Company’s global branded specialty pharmaceutical business, which develops and markets a portfolio of approximately 40 products principally in the United States and Canada that are focused in the Urology and Women’s Health therapeutic categories. Actavis Specialty Brands is committed to developing and marketing biosimilars products in Women’s Health, Oncology and other therapeutic categories, and currently has a portfolio of 5 biosimilar products in development. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, with a capacity of approximately 40 billion units annually. Actavis Global Operations also includes Anda, Inc., the fourth-largest U.S. generic pharmaceutical product distributor in the United States.